» Articles » PMID: 35663558

MicroRNA Alterations in Chronic Traumatic Encephalopathy and Amyotrophic Lateral Sclerosis

Abstract

Repetitive head impacts (RHI) and traumatic brain injuries are risk factors for the neurodegenerative diseases chronic traumatic encephalopathy (CTE) and amyotrophic lateral sclerosis (ALS). ALS and CTE are distinct disorders, yet in some instances, share pathology, affect similar brain regions, and occur together. The pathways involved and biomarkers for diagnosis of both diseases are largely unknown. MicroRNAs (miRNAs) involved in gene regulation may be altered in neurodegeneration and be useful as stable biomarkers. Thus, we set out to determine associations between miRNA levels and disease state within the prefrontal cortex in a group of brain donors with CTE, ALS, CTE + ALS and controls. Of 47 miRNAs previously implicated in neurological disease and tested here, 28 (60%) were significantly different between pathology groups. Of these, 21 (75%) were upregulated in both ALS and CTE, including miRNAs involved in inflammatory, apoptotic, and cell growth/differentiation pathways. The most significant change occurred in miR-10b, which was significantly increased in ALS, but not CTE or CTE + ALS. Overall, we found patterns of miRNA expression that are common and unique to CTE and ALS and that suggest shared and distinct mechanisms of pathogenesis.

Citing Articles

Upregulated miR-10b-5p as a potential miRNA signature in amyotrophic lateral sclerosis patients.

Dash B, Freischmidt A, Helferich A, Ludolph A, Andersen P, Weishaupt J Front Cell Neurosci. 2024; 18:1457704.

PMID: 39588282 PMC: 11586771. DOI: 10.3389/fncel.2024.1457704.


Exploring dysregulated miRNAs in ALS: implications for disease pathogenesis and early diagnosis.

Maity D, Kaundal R Neurol Sci. 2024; .

PMID: 39570437 DOI: 10.1007/s10072-024-07840-x.


A microRNA diagnostic biomarker for amyotrophic lateral sclerosis.

Banack S, Dunlop R, Mehta P, Mitsumoto H, Wood S, Han M Brain Commun. 2024; 6(5):fcae268.

PMID: 39280119 PMC: 11398878. DOI: 10.1093/braincomms/fcae268.


Argonaute protein assisted drug discovery for miRNA-181c-5p and target gene ATM translation repression: a computational approach.

Tak H, Anirudh J, Chattopadhyay A, Naick B Mol Divers. 2024; 29(1):351-365.

PMID: 39026118 DOI: 10.1007/s11030-024-10855-3.


Blood-Based Biomarkers in the Diagnosis of Chronic Traumatic Encephalopathy: Research to Date and Future Directions.

Halicki M, Hind K, Chazot P Int J Mol Sci. 2023; 24(16).

PMID: 37628736 PMC: 10454393. DOI: 10.3390/ijms241612556.


References
1.
McKee A, Stern R, Nowinski C, Stein T, Alvarez V, Daneshvar D . The spectrum of disease in chronic traumatic encephalopathy. Brain. 2012; 136(Pt 1):43-64. PMC: 3624697. DOI: 10.1093/brain/aws307. View

2.
Cherry J, Agus F, Dixon E, Huber B, Alvarez V, Mez J . Differential gene expression in the cortical sulcus compared to the gyral crest within the early stages of chronic traumatic encephalopathy. Free Neuropathol. 2021; 2. PMC: 8415801. DOI: 10.17879/freeneuropathology-2021-3453. View

3.
Korley F, Diaz-Arrastia R, Wu A, Yue J, Manley G, Sair H . Circulating Brain-Derived Neurotrophic Factor Has Diagnostic and Prognostic Value in Traumatic Brain Injury. J Neurotrauma. 2015; 33(2):215-25. PMC: 4722554. DOI: 10.1089/neu.2015.3949. View

4.
Si Y, Cui X, Crossman D, Hao J, Kazamel M, Kwon Y . Muscle microRNA signatures as biomarkers of disease progression in amyotrophic lateral sclerosis. Neurobiol Dis. 2018; 114:85-94. PMC: 5891369. DOI: 10.1016/j.nbd.2018.02.009. View

5.
Cherry J, Tripodis Y, Alvarez V, Huber B, Kiernan P, Daneshvar D . Microglial neuroinflammation contributes to tau accumulation in chronic traumatic encephalopathy. Acta Neuropathol Commun. 2016; 4(1):112. PMC: 5084333. DOI: 10.1186/s40478-016-0382-8. View